Location: Virtual | 10:30 p.m. – 11:30 p.m. ET*
The third webinar in our series focuses on reducing the risk of materials becoming a transmission vector for microorganisms when they are transferred into an aseptic environment or staged for production activities.
We cover the development of mitigation measures, documentation and training strategies to reduce risk and improve productivity. We also review best practices for equipment preparation/wrapping, manual surface disinfection and disinfection using Vaporized Hydrogen Peroxide (VHP) pass-through chambers.
* Please note that the webinar broadcast time is listed in the Eastern Time Zone (ET). If necessary, be sure to convert to your local time zone.
Thank you for your interest, but the broadcast date for this webinar has passed. Please refer to our Events page to view upcoming events.
Don't Miss the Final Webinar in Our Cell and Gene Therapy Webinar Series
Cell and Gene Therapy Panel Discussion
Wednesday, December 13, 2023
10:30 p.m. – 11:30 p.m. ET
Meet the Presenters
Renee Buthe | Technical Services Manager
Renee has over seven years of industry experience, specifically in cell and gene therapies. She has expertise in generating protocols for and performing environmental monitoring, airflow visualization studies and aseptic process simulations, reviewing batch records and authoring final reports. Renee holds a bachelor’s degree in biology.
At STERIS Life Sciences, Renee assists Customers with sterility assurance and sterility maintenance product applications.
Renee is currently an instructor through the Parenteral Drug Association (PDA) training institute and an active member of the association.
Aaron Mertens | Senior Manager, Technical Services
Aaron has over two decades of experience in pharmaceutical manufacturing, with expertise in cleaning, disinfection, sterilization and contamination control. He has held several positions within the pharmaceutical industry, with experience working at pharmaceutical manufacturing organizations representing quality assurance programs and working with global industry regulatory agencies. He holds a bachelor’s degree in genetics.
At STERIS Life Sciences, Aaron performs global manufacturing site evaluations and consultations to ensure compliance with international regulations. He is also responsible for providing global technical support for critical environments, sterility assurance and sterility maintenance application and validation.
Aaron is an active member of the Parenteral Drug Association (PDA) and the International Society for Pharmaceutical Engineering (ISPE). He previously served as President of the ISPE Great Lakes Chapter and is currently on the chapter’s Board of Directors. He is also a member of the ISPE Sterile Products Processing Steering Committee.
Additional professional activities for Aaron include delivering technical content to the industry with posters, publications, virtual and live technical presentations, as well as leading global sterilization master classes.